- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4525 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
Patent holdings for IPC class A61K 31/4525
Total number of patents in this class: 775
10-year publication summary
|
49
|
66
|
66
|
61
|
84
|
68
|
66
|
58
|
62
|
23
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11011 |
14 |
| Centre National de La Recherche Scientifique | 10227 |
11 |
| Merck Sharp & Dohme LLC | 3728 |
11 |
| Vertex Pharmaceuticals Incorporated | 1591 |
10 |
| Glytech, LLC | 16 |
10 |
| Clexio Biosciences Ltd. | 101 |
10 |
| Boehringer Ingelheim International GmbH | 4725 |
9 |
| Neurocrine Biosciences, Inc. | 400 |
9 |
| Southern Methodist University | 120 |
9 |
| The Regents of the University of California | 19705 |
8 |
| Cipla Limited | 466 |
8 |
| Lixte Biotechnology, Inc. | 63 |
8 |
| Bristol-myers Squibb Company | 4848 |
7 |
| Takeda Pharmaceutical Company Limited | 2693 |
7 |
| Arena Pharmaceuticals, Inc. | 366 |
7 |
| Kyushu University, National University Corporation | 1636 |
7 |
| Sagimet Biosciences Inc. | 24 |
7 |
| Alectos Therapeutics Inc. | 49 |
6 |
| Valbiotis | 38 |
6 |
| Universite Clermont Auvergne | 132 |
6 |
| Other owners | 605 |